MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.omtn.2025.102807

Медицинская библиотека · Molecular therapy. Nucleic acids · 2025

Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis.

Zhong Jiewen, Zhang Zheyu, Xiao Lixing, Wang Cheng, Yang Yun, Zhang Qinghao, Wang Zefeng

СтатьяПеревод пока не подготовлен

Аннотация

Circular RNAs (circRNAs) have recently emerged as a promising new drug modality with significant therapeutic potential due to their higher stability and lower immunogenicity. Here, we report the development of a circRNA encoding human relaxin-2 (cRLN2), a short peptide hormone with well-established therapeutic potential, to treat liver fibrosis in a mouse model. Compared to the modified linear mRNA, cRLN2 mediated stronger and more prolonged expression of relaxin in vitro. In addition, the nanoparticle-mediated delivery of cRLN2 achieved a sustained translation into active relaxin in healthy mice with low immunogenicity. In a mouse model of liver fibrosis, cRLN2 treatment significantly decreased hepatic stellate cell activation and consequently reduced collagen deposition in fibrotic mice, while the treatment by relaxin protein showed limited anti-fibrosis effects. Toxicity evaluation confirmed that cRLN2 exhibits excellent safety and tolerability in mice. Collectively, our findings demonstrate that cRLN2 can efficiently express therapeutic proteins in vivo and alleviate liver fibrosis without obvious toxic effects, highlighting the potential of circRNAs as a novel therapeutic platform to treat fibrotic diseases.

Для цитирования: Zhong Jiewen, Zhang Zheyu, Xiao Lixing, Wang Cheng, Yang Yun, Zhang Qinghao, Wang Zefeng. Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis.. Molecular therapy. Nucleic acids. 2025. DOI: 10.1016/j.omtn.2025.102807.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.